The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(3-(3-(5-((4-(2-chlorophenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-ylthio)methyl)-1,2,4-oxadiazol-3-yl)phenoxy)propoxy)propan-1-amine ID: ALA2325219
PubChem CID: 68166517
Max Phase: Preclinical
Molecular Formula: C28H28ClN7O3S
Molecular Weight: 578.10
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NCCCOCCCOc1cccc(-c2noc(CSc3nnc(-c4ccncc4)n3-c3ccccc3Cl)n2)c1
Standard InChI: InChI=1S/C28H28ClN7O3S/c29-23-8-1-2-9-24(23)36-27(20-10-13-31-14-11-20)33-34-28(36)40-19-25-32-26(35-39-25)21-6-3-7-22(18-21)38-17-5-16-37-15-4-12-30/h1-3,6-11,13-14,18H,4-5,12,15-17,19,30H2
Standard InChI Key: LLSIXRBOETXJEL-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
5.7850 1.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7838 0.8484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4919 0.4402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2015 0.8479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1987 1.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4901 2.0798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4903 -0.3813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8291 -0.8615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0814 -1.6388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8987 -1.6390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1513 -0.8619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9254 -0.6087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5325 -1.1574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3092 -0.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4798 -0.1055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8677 0.4492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0935 0.1921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0520 -0.6088 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.4445 -1.1555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6674 -0.9028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4156 -0.1235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5984 -0.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3457 -0.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0068 -1.3808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5678 -1.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9606 -0.6071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1874 -0.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0196 -1.6591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6255 -2.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3998 -1.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4563 -3.0063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0640 -3.5526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8948 -4.3521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5025 -4.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3333 -5.6979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9410 -6.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7718 -7.0436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3796 -7.5899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2103 -8.3894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0758 0.4392 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
3 7 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 12 1 0
8 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 2 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
23 25 1 0
29 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 1 0
2 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 578.10Molecular Weight (Monoisotopic): 577.1663AlogP: 5.46#Rotatable Bonds: 14Polar Surface Area: 127.00Molecular Species: BASEHBA: 11HBD: 1#RO5 Violations: 3HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 10.14CX LogP: 4.11CX LogD: 1.49Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.13Np Likeness Score: -2.09
References 1. Voronkov A, Holsworth DD, Waaler J, Wilson SR, Ekblad B, Perdreau-Dahl H, Dinh H, Drewes G, Hopf C, Morth JP, Krauss S.. (2013) Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor., 56 (7): [PMID:23473363 ] [10.1021/jm4000566 ]